The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability: A Randomized Controlled Trial (ATRASI)

Eligibility

Inclusion Criteria:
The inclusion criterion for the study is the presence of glenoid and/or humerus bone loss on imaging tests (X-Ray, CT Scan, or MRI), recurrent anterior shoulder dislocation (two or more incidents) in a competent patient between the ages of 16 and 60.

Exclusion Criteria:

Exclusion criteria for the study are patients with prior surgery of the affected shoulder; multi-directional instability; posterior instability; presence of cuff tear and/or Humeral Avulsion Glenohumeral Ligament (HAGL)/Reverse HAGL (rHAGL); uncontrolled diabetes; pregnancy; cancer or other severe illnesses.

Contact

  • iw@drivanwong.com,   902-473-2114,  Ivan.Wong@nshealth.ca

PI
Dr Ivan Wong

Description

The objective of this study is to compare the arthroscopic Bankart to arthroscopic anatomic glenoid reconstruction (AAGR) for treating recurrent anterior instability. The Western Ontario Shoulder Instability (WASI) Index will be conducted two-years post-op as the primary determinant of outcomes. Examining patients’ range of motion (ROM), strength, safety, the Disabilities of the Arm Shoulder and Hand (DASH) questionnaire, and CT outcomes will be used as secondary determinants of outcomes.

Sample size= 200